Dr. Bernold Beckenbauer

Global CFO role overseeing all financial activities of Linde Hydrogen Fueltech’s business in Europe, US, Korea and China and leading a team of 10 persons. Additionally, member of the leadership team, CFO of the Linde Hydrogen Fueltech joint venture in China and Head of IT.

Leading M&A projects in Asia and the EMEA region for Linde plc. Activities include market search & screening for acquisitions/alliances/collaborations, due diligence, financial business case development, valuation of the opportunities, deal negotiations and presentation of projects to senior management. Independent coordination of the M&A and business development activities with various functions within Linde plc.

Leading M&A and carve-out projects (e.g. Linde Pakistan, IG business in India & Tega Germany). Member of the M&A team leading the Linde-Praxair merger being one of the largest German M&A transactions of the year 2017. Coordinating advisors as part of the Linde-Praxair Merger with the key achievement being the successful sale of Linde Korea for 1.2bnEUR to a Korean PE company in 2018.

Leading the Linde Healthcare Market Intelligence department, supporting global healthcare strategy development by identifying business opportunities. Preparation of the 10 year strategy book for the Linde Group. Identifying priority clusters, regions and lead geographic studies. Developing high-level long-term resource plans in cooperation with finance and controlling.

Evaluating and bringing new products, partnerships and technologies into the Linde organization. Definition of a new global integrated care vision for Linde Healthcare to expand its current business model and alignment with corporate, regional and country stakeholders. Initiated rollout of the concept in seven key countries.

Responsible for controlling & customer service of the transfusion business of Fresenius Kabi for the Region EME. Successfully completed and led the financial integration of Fenwal Inc. within six months into the Fresenius Kabi Group (Region EME) with go-live in July 2013. Management of more than 20 reporting units and a P&L of more than 100 EURm.

Responsible for business development of the compounding business and strategic planning for all product areas of Fresenius Kabi in the Asia Pacific Region. Successful setup of the first cooperation between Fresenius Kabi and Pfizer being Pfizer´s first sales cooperation with a 3rd party in Asia.

Post-merger integration of Dabur Pharma Ltd. in the Fresenius Kabi Group. Reporting to the local CFO and managing interdisciplinary projects mainly in the areas of controlling and production expansion. Additionally a role as market unit controller.

Negotiation Mastery: Negotiation Mastery prepares students to close deals that might otherwise be dead-locked, maximize value creation in agreements, and resolve differences before they escalate into costly conflicts.

See Certificate: https://www.cvtrust.com/SmartCertificate/?kAhVZXR4o6HFPTgHA5XIuN6VimihE9PiPWfS0pCraXmdZL%2f1irUpe%2frzN1SiuHvG